search

PubMed Search Builder

Purinergic Agonists [Pharmacological Action]

Tree Number(s): D058913
MeSH Unique ID: D058913
Entry Terms:
  • 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphate (Supplementary Concept)
  • 2'-deoxyribose-N6-cyclopentyladenosine (Supplementary Concept)
  • 2-((1-phenylpropyl)amino)adenosine (Supplementary Concept)
  • 2-((phenylisopropyl)amino)adenosine (Supplementary Concept)
  • 2-(2-phenylethoxy)adenosine (Supplementary Concept)
  • 2-(3''-(6''-bromoindolyl)ethyloxy)adenosine (Supplementary Concept)
  • 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)-5'-N-ethylcarboxamidoadenosine (Supplementary Concept)
  • 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine (Supplementary Concept)
  • 2-amino-4-(4-hydroxyphenyl)-6-(1H-imidazol-2-ylmethylsulfanyl)pyridine-3,5-dicarbonitrile (Supplementary Concept)
  • 2-amino-4-benzo(1,3)dioxol-5-yl-6-(2-hydroxyethylsulfanyl)pyridine-3,5-dicarbonitrile (Supplementary Concept)
  • 2-chloro-N(6)-(3-iodobenzyl)-5'-N-methylcarbamoyl-4'-thioadenosine (Supplementary Concept)
  • 2-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide (Supplementary Concept)
  • 2-chloro-N(6)-methyladenosine-5'-methyluronamide (Supplementary Concept)
  • 2-hexyloxyadenosine (Supplementary Concept)
  • 2-methylthio-ATP (Supplementary Concept)
  • 3-phenacyluridine diphosphate (Supplementary Concept)
  • 4'-(2-chloro-6-(3-iodobenzylamino)purine)-2',3'-O-dihydroxy-bicyclo(3.1.0)hexane (Supplementary Concept)
  • 5'-O-ethyl-N-(3-iodobenzyl)adenosine (Supplementary Concept)
  • 8-butylamino-N(6)-cyclopentyladenosine (Supplementary Concept)
  • 8-butylaminoadenosine (Supplementary Concept)
  • 8-carboxy-iso-iantheran A (Supplementary Concept)
  • 8-methylamino-N6-cyclopentyladenosine (Supplementary Concept)
  • ABEA-X-BY630 (Supplementary Concept)
  • Adenosine (MeSH Term)
  • aminopyridine-3,5-dicarbonitrile (Supplementary Concept)
  • BAY 60-6583 (Supplementary Concept)
  • binodenoson (Supplementary Concept)
  • CF 502 (Supplementary Concept)
  • CVT 2759 (Supplementary Concept)
  • ethyl 2-amino-3-benzoyl-4,7-dihydrothieno(2,3-c)pyridine-6(5H)-carboxylate (Supplementary Concept)
  • GW 328267 (Supplementary Concept)
  • INS 48823 (Supplementary Concept)
  • iso-iantheran A (Supplementary Concept)
  • iso-iantheran B (Supplementary Concept)
  • KMCP 98 (Supplementary Concept)
  • MRS 2219 (Supplementary Concept)
  • N(6)-(4-sulfophenyl)adenosine (Supplementary Concept)
  • N(6)-benzyl-5'-N-ethylcarboxamidoadenosine (Supplementary Concept)
  • N(6)-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (Supplementary Concept)
  • N(6)-cyclopentyladenosine (Supplementary Concept)
  • N-((1S,trans)-2-hydroxycyclopentyl)adenosine (Supplementary Concept)
  • N-(3-iodobenzyl)-5'-O-methyladenosine (Supplementary Concept)
  • N6-(4-(((4-((((2-((((isothiocyanatophenyl)amino)thiocarbonyl)amino)ethyl)amino)carbonyl)methyl)anilino)carbonyl)methyl)phenyl)adenosine (Supplementary Concept)
  • N6-methoxy-2-(4-acetylphenyl)ethynyl-5'-N-methylcarboxamidoadenosine (Supplementary Concept)
  • PSB-0777 (Supplementary Concept)
  • regadenoson (Supplementary Concept)
  • RS 74513-000 (Supplementary Concept)
  • tecadenoson (Supplementary Concept)
  • VUF 5455 (Supplementary Concept)

Comments (0)

No login
gif